Who owns Array BioPharma?

Key details on Array BioPharma (Ticker: ARRY)

Who owns Array BioPharma?

Is ARRY a good stock to own? Find out who bought Array BioPharma, who sold Array BioPharma (ARRY) stock, and who holds a large position in Array BioPharma.

Fund Name Number of Shares Share Valuation As Of
FMR 18.68M $78.83M Dec. 31, 2015
Redmile 17.75M $80.94M Sept. 30, 2015
OrbiMed Advisors 10.06M $45.88M Sept. 30, 2015
Deerfield Management Company 9.73M $44.37M Sept. 30, 2015
BVF 9.68M $44.14M Sept. 30, 2015
Vanguard 8.01M $34.05M Dec. 31, 2015
STATE STREET CORPORATION 6.46M $29.46M Sept. 30, 2015
T. Rowe Price Associates 5.14M $23.45M Sept. 30, 2015
BlackRock Fund Advisors 5.10M $21.52M Dec. 31, 2015
Baker Bros. Advisors 4.31M $19.66M Sept. 30, 2015
QVT Financial 4.30M $21.11M March 31, 2013
Artal Group S.A. 4.01M $18.29M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 3.86M $27.82M June 30, 2015
Gail Mannix 3.82M $27.54M June 30, 2015
TimesSquare Capital Management 3.79M $27.29M June 30, 2015

Who sold Array BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management June 30, 2011 4.40M $9.85M